RISE Session - Physician Only

SRS/SBRT in the Setting of Re-Irradiation:
Indications, Safety and Efficacy (RISE)

Presented at the SRS/SBRT Scientific Meeting 2016 by:

  • Anthony Dragun, MD, Associate Professor and Vice Chairman of Radiation Oncology University of Louisville School of Medicine, Louisville, KY
  • John Flickinger, MD, Department of Radiation Oncology Neurological Surgery, University of Pittsburgh School of Medicine, UPMC-Presbyterian Shadyside Hospitals and the Pittsburgh Cancer Institute, Pittsburgh, PA
  • Dwight E. Heron, MD FACRO FACR, Professor of Radiation Oncology & Otolaryngology, Head & Neck Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Jun Yang, PhD, Drexel University, Alliance Oncology and Philly Cyberknife, Philadelphia, PA

This course is available from June 13, 2016 through 11:59 p.m. Eastern time on June 13, 2019.

In order to earn credit for this course, participants must:

    • View the audio/slide presentation
    • Pass the five-question examination with a minimum of 70 percent, and
    • Complete the course evaluation.  
The activity is approximately 2 hours in length. 


Local tumor recurrences after radiation therapy pose a clinical management dilemma with limited treatment options. The ability to deliver efficacious doses of radiation to the recurrent lesion are limited by the potential toxicities to normal tissues when considering re-irradiation. Stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) have been shown to be effective at local control with limited toxicities for CNS and spine lesions, recurrent head and neck tumors and locoregional breast cancer recurrences in the setting of re-irradiation. There is a need to improve therapy for recurrent tumors previously irradiated and SRS/SBRT may be a viable treatment option for select patients. The optimal SRS/SBRT dose, fractionation regimens and integration with chemotherapy and biologic agents needs to be further defined to maximize the therapeutic benefits.


This program is designed to meet the needs of radiation oncologists, neurosurgeons, medical physicists, residents-in-training and healthcare professionals with interest in SRS/SBRT in the setting of re-irradiation for the treatment of recurrent CNS and spine lesions, recurrent head and neck tumors, and locoregional breast cancer recurrences.


  • Explain the clinical challenges of treating tumor recurrences that have been previously irradiated, and the role of SRS/SBRT in the setting of re-irradiation through evidence-based literature.
  • Describe the indications and patient selection for SRS/SBRT in the setting of re-irradiation for the treatment of CNS and spine tumors, recurrent head and neck tumors and loco-regional recurrent breast cancer.
  • Discuss the principles of radiobiology and treatment planning to deliver SRS/SBRT in the setting of re-irradiation for the treatment of CNS and spine tumors, recurrent head and neck tumors and loco-regional recurrent breast cancer.
  • Understand the toxicities associated with SRS/SBRT used in the treatment management of previously irradiated CNS and spine tumors, recurrent head & neck tumors and loco-regional recurrent breast cancer.


In order to successfully complete this knowledge-based continuing education activity, the participant must register for the activity, view the educational sessions, and complete the online examination and activity evaluation.


The Radiosurgery Society Self-Assessment Module (SAM) titled SRS/SBRT Reirradation: Indications, Safety and Efficacy is qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has been qualified for 2 SAM credits. The ABR qualified this SAM on June 13, 2016.


A certificate will be issued upon completion of course requirements, including the evaluation, enabling you to register your credit with the appropriate licensing boards or associations.


  • Non-Member: $10
  • RSS Member: Free (your discount has been emailed to you)


Software Requirements

  • A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher

A note on browser incompatibility:

  • We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
  • Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
  • Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot. http://get.adobe.com/flashplayer/

Hardware Requirements

  • Windows Based Computer, Mac based Computers, smart phone, tablets
  • Windows XP SP 3 or Vista Home Premium or better
  • Mac OS x 10.5.3 or better
  • Pentium 4 or better
  • 1meg of System Ram (Memory)
  • True Color 32 bit video card
  • Soundcard and speakers
For more help with technical issues please click here.


No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.

Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.

Please contact admin@therss.org if you have questions.

Member login  

the RSS would like to
acknowledge and thank our 
Corporate Sponsors.


the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice

the RSS is pleased to collaborate with the following:

Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype